(Q64087446)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

title

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

0 references

0 references

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Yajing Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Tingting Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Heng Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Xuan Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Qing Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Mei Yu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Sheng-Han Kuo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Fang Huang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

Yun-Cheng Wu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

28 February 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

Frontiers in Aging Neuroscience

29 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

29 April 2020

copyright license

start time

28 February 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease

1 reference

12 December 2020

Induction of NF-kappaB by the Akt/PKB kinase

1 reference

12 December 2020

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

1 reference

12 December 2020

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

1 reference

12 December 2020

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

1 reference

12 December 2020

Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

1 reference

12 December 2020

The involvement of NF-kappaB p65/p52 in the effects of GDNF on DA neurons in early PD rats

1 reference

12 December 2020

MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target

1 reference

12 December 2020

Mechanisms underlying inflammation in neurodegeneration

1 reference

12 December 2020

Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis

1 reference

12 December 2020

Inhibiting NF-κB activation by small molecules as a therapeutic strategy

1 reference

12 December 2020

Dl-3-n-butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease

1 reference

12 December 2020

DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium.

1 reference

12 December 2020

dl-3n-Butylphthalide promotes angiogenesis via the extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase/Akt-endothelial nitric oxide synthase signaling pathways.

1 reference

12 December 2020

Protection against neurotoxicity by an autophagic mechanism

1 reference

12 December 2020

NRSF/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP

1 reference

12 December 2020

Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia

1 reference

12 December 2020

Small molecule inhibitors targeting activator protein 1 (AP-1).

1 reference

12 December 2020

l-3-n-Butylphthalide attenuates β-amyloid-induced toxicity in neuroblastoma SH-SY5Y cells through regulating mitochondrion-mediated apoptosis and MAPK signaling

1 reference

12 December 2020

The ongoing pursuit of neuroprotective therapies in Parkinson disease

1 reference

12 December 2020

Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis

1 reference

12 December 2020

The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.

1 reference

12 December 2020

Tiagabine Protects Dopaminergic Neurons against Neurotoxins by Inhibiting Microglial Activation

1 reference

12 December 2020

L-3-n-Butylphthalide attenuates neuroinflammatory responses by downregulating JNK activation and upregulating Heme oxygenase-1 in lipopolysaccharide-treated mice.

1 reference

12 December 2020

Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.

1 reference

12 December 2020

Evaluation of Models of Parkinson's Disease

1 reference

12 December 2020

Animal behavioral assessments in current research of Parkinson's disease.

1 reference

12 December 2020

Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke

1 reference

12 December 2020

Rice bran derivatives alleviate microglia activation: possible involvement of MAPK pathway

1 reference

12 December 2020

How neuroinflammation contributes to neurodegeneration

1 reference

12 December 2020

Phosphoinositide-3-kinases as the novel therapeutic targets for the inflammatory diseases: Current and future perspectives

1 reference

12 December 2020

Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.

1 reference

12 December 2020

NADPH oxidase-derived H2O2 mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson's disease

1 reference

12 December 2020

The two-century journey of Parkinson disease research

1 reference

12 December 2020

DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice.

1 reference

12 December 2020

The potential role of neuroinflammation and transcription factors in Parkinson disease

1 reference

12 December 2020

Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study

1 reference

12 December 2020

The efficacy and safety of Dl-3n-butylphthalide on progressive cerebral infarction: A randomized controlled STROBE study

1 reference

12 December 2020

Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling.

1 reference

12 December 2020

Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease.

1 reference

12 December 2020

The protective effect and its mechanism of 3-n-butylphthalide pretreatment on cerebral ischemia reperfusion injury in rats

1 reference

12 December 2020

DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice.

1 reference

12 December 2020

TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.

1 reference

12 December 2020

Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease.

1 reference

12 December 2020

Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?

1 reference

12 December 2020

Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease

1 reference

12 December 2020

Identifiers

DOI

10.3389/FNAGI.2019.00044

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30873019%20AND%20SRC:MED&resulttype=core&format=json

29 April 2020

1 reference